Are MRAs the Secret Weapon Against Hormonal Hypertension?

Published: Jan 16, 2024

For those battling primary aldosteronism, mineralocorticoid receptor antagonists (MRAs) could be the game-changer in managing blood pressure. Discover how these medications work and who they can help.
Contents

The Role of MRAs in Treatment

MRAs like spironolactone and eplerenone are key players in treating primary aldosteronism, especially for those who cannot undergo surgery. These drugs block the effects of aldosterone, helping to regulate blood pressure and potassium levels. They are often the first-line treatment for bilateral adrenal disease.

Choosing Between Spironolactone and Eplerenone

Spironolactone is the go-to choice due to its effectiveness and affordability, but it can cause side effects like breast tenderness. Eplerenone is more selective and has fewer side effects but is generally more expensive. Patients often start with spironolactone and switch to eplerenone if needed.
Mineralocorticoid Receptor Antagonists (MRAs) like spironolactone and eplerenone are used to treat primary aldosteronism by blocking aldosterone, helping regulate blood pressure and potassium levels.

Monitoring and Adjusting Treatment

Regular monitoring of blood pressure, potassium, and creatinine levels is crucial when using MRAs. Adjustments to dosage may be necessary to achieve optimal results. Monitoring helps avoid potential side effects and ensures the treatment is effective.

Frequently Asked Questions

Drugs that block aldosterone to manage blood pressure.

It's effective, affordable, but may have more side effects.

Blood pressure, potassium, and creatinine levels.

Yes, especially in bilateral adrenal disease or nonsurgical candidates.

The Bottom Line

Could MRAs be the key to controlling your aldosterone-driven hypertension?
Wondering if MRAs could help you? Consult with Doctronic to learn more!

Related Articles

References

  1. Ghose RP, Hall PM, Bravo EL. Medical management of aldosterone-producing adenomas. Ann Intern Med 1999; 131:105.
  2. Parthasarathy HK, MΓ©nard J, White WB, et al. A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism. J Hypertens 2011; 29:980.

This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.

AI Doctor Visit Required

Appointments available 24/7

πŸ˜€ πŸ˜€ πŸ˜€
stethoscope

Top licensed doctors

Available in all 50 states

dossier

Full service care

Prescriptions, referrals & treatment

check

No insurance needed

All notes available in Doctronic

15-min consultation. No hidden costs.

AI Doctor Visit Required
Close icon

Please Chat With Our AI Doctor First

Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care

Lifebuoy

For safety reasons we have been forced to end this consultation.

If you believe this is a medical emergency please call 911 or your local emergency services immediately.

If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.

Contact us

You can also email us at help@doctronic.ai

We aim to reply within 5-7 days

How likely are you to recommend Doctronic to friends or family?
Not likely at all Extremely likely